Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bakumijiogan (BJG) is a traditional herbal formula used in Kampo (Japanese traditional medicine) and Traditional Chinese Medicine (TCM), where it is known as Mai Wei Di Huang Wan. It is a modification of the classic Liu Wei Di Huang Wan (Rokumijiogan) formula, created by adding Ophiopogon tuber (Bakumondo) and Schisandra fruit (Gomishi) to the base of six herbs: Rehmannia root, Cornus fruit, Dioscorea rhizome, Alisma rhizome, Poria sclerotium, and Moutan bark. BJG is primarily indicated for conditions involving 'dryness' and 'heat,' such as chronic dry cough, asthma, and atopic dermatitis. Its mechanism of action involves modulating the immune response by correcting the Th1/Th2 imbalance; specifically, it has been shown to increase the production of Th1 cytokines like interferon-gamma (IFN-γ) while suppressing Th2-mediated responses, including the production of IgE and pro-inflammatory cytokines like IL-1α and TNF-α.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bakumijiogan.